+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Topical Hemostat Market - Global Forecast 2026-2032- Product Image
Topical Hemostat Market - Global Forecast 2026-2032- Product Image
Sale

Topical Hemostat Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4989882
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Topical Hemostat Market is projected to reach USD 7.20 Billion in 2026. It is expected to continue growing at a CAGR of 8.06%, reaching USD 11.51 Billion by 2032.

Topical hemostats are an essential category of surgical bleeding control products used when conventional techniques such as pressure, sutures, clips, cautery, or ligation are insufficient or impractical. The market spans absorbable mechanical agents, active thrombin-based products, flowable hemostatic matrices, fibrin sealants, synthetic sealants, and combination products used across cardiovascular, orthopedic, neurosurgical, general, trauma, obstetric, and minimally invasive procedures.

Demand is supported by persistent surgical volume, population aging, rising comorbidity burden, wider use of anticoagulant and antiplatelet therapies, and the clinical priority of reducing blood loss, transfusion exposure, operating-room time, and postoperative complications. For manufacturers, hospitals, and investors, competitive advantage is increasingly tied to proven hemostatic performance, fast preparation, biocompatibility, transparent total-cost evidence, and regulatory compliance across major markets.

Transformative Shifts Reshaping Topical Hemostasis

The topical hemostat landscape is moving from commodity surgical adjuncts toward procedure-specific, evidence-led bleeding control solutions. Surgeons increasingly select products based on bleeding intensity, anatomical constraints, absorbability, swelling profile, delivery format, and compatibility with minimally invasive and robotic workflows. This shift favors ready-to-use flowables, sprayable sealants, and applicators designed for narrow or difficult-to-access surgical fields.

Regulatory expectations are also transforming the market. The U.S. FDA treats many thrombin, fibrin, and combination hemostats as biologics, devices, or combination products depending on composition and claims, while the European Union Medical Device Regulation has increased clinical evidence, post-market surveillance, and documentation requirements. As a result, suppliers with robust clinical data, validated quality systems, and reliable plasma, collagen, gelatin, cellulose, or synthetic polymer sourcing are better positioned than firms competing primarily on price.

Cumulative Impact of Artificial Intelligence on Topical Hemostats

Artificial intelligence is beginning to influence the topical hemostat value chain through demand planning, evidence synthesis, manufacturing optimization, quality monitoring, and clinical decision support. In hospitals, AI-enabled analytics can identify procedure types, surgeon preference patterns, transfusion risk, and product utilization variance, helping supply-chain teams standardize formularies without compromising clinical choice.

For manufacturers, machine learning can improve batch consistency, predict raw-material deviations, monitor sterilization and packaging quality, and accelerate post-market surveillance by analyzing complaint trends, adverse-event narratives, and real-world safety signals. AI does not replace surgeon judgment at the point of bleeding control, but it can make product selection, inventory planning, clinical education, and health-economic evidence more precise, especially where hospitals are under pressure to reduce waste and prove value.

Key Regional Insights Across Topical Hemostat Demand

North America remains a high-value region for topical hemostats because of advanced surgical infrastructure, strong adoption of biologic and combination hemostats, established blood-management practices, and hospital focus on FDA-cleared or FDA-approved products. Europe is shaped by mature surgical demand, centralized procurement in many countries, and the EU MDR, which has raised the importance of clinical documentation, post-market surveillance, traceability, and real-world evidence.

Asia-Pacific is an expanding opportunity base, driven by rising surgical access, private hospital investment, medical tourism, and growing domestic medtech capacity across China, India, Japan, South Korea, Australia, and ASEAN economies. Latin America, led by Brazil and Mexico, shows increasing demand in tertiary hospitals and private networks but remains sensitive to reimbursement, tender pricing, and currency volatility. The Middle East is supported by specialty hospital investment, trauma and complex-care capabilities, and GCC healthcare modernization, while Africa offers long-term potential through trauma care, maternal health, and surgical-capacity expansion, although affordability, training, cold-chain needs for some biologic products, and distribution reliability remain key constraints.

Key Group Insights for Strategic Market Positioning

Among regional blocs, the G7 anchors premium topical hemostat adoption through high procedure intensity, established reimbursement pathways, advanced operating-room infrastructure, and stringent product evaluation. The European Union is influential because EU MDR compliance affects not only member states but also global manufacturers that use CE-marked portfolios for international registration and procurement access. NATO markets overlap significantly with high-income healthcare systems where surgical readiness, trauma management, emergency preparedness, and supply resilience are strategic priorities.

BRICS economies represent a dual opportunity: China, India, and Brazil are expanding access to advanced surgery, while domestic production, tender discipline, and cost containment increasingly shape procurement. ASEAN is important for medical tourism, private hospital chains, and improving surgical infrastructure in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. The GCC is a premium regional cluster where hospital modernization, specialist centers, government-funded healthcare investment, and international accreditation support adoption of advanced hemostatic products when supported by clinical and economic evidence.

Key Country Insights in Priority Topical Hemostat Markets

The United States is the largest commercial opportunity for advanced topical hemostats because of high surgical intensity, strong specialty care, hospital blood-management initiatives, and established pathways for FDA-regulated hemostatic agents. Canada emphasizes evidence, safety, health technology assessment, and provincial procurement discipline, while Mexico combines private hospital growth with public-sector cost sensitivity. Brazil is Latin America's leading topical hemostat market, supported by tertiary care capacity and complex surgery, although reimbursement variability and tender dynamics affect uptake.

In Europe, the United Kingdom, Germany, France, Italy, and Spain show mature demand shaped by hospital value committees, clinical guidelines, national reimbursement structures, and EU MDR-related evidence requirements, while Russia remains affected by localization, procurement, and geopolitical supply considerations. China and India offer substantial growth as surgical access expands, but pricing, volume-based purchasing, tenders, and local competition are decisive. Japan and South Korea are quality-focused markets with advanced surgical adoption and strict regulatory expectations, while Australia rewards products that demonstrate safety, usability, supply reliability, and measurable value within a well-regulated healthcare system.

Actionable Recommendations for Topical Hemostat Leaders

Industry leaders should prioritize differentiated clinical evidence that links topical hemostat performance to reduced bleeding-related complications, transfusion avoidance, shorter procedure time, improved workflow efficiency, and lower total cost of care. Product portfolios should be segmented by bleeding severity, procedure type, access route, absorbability, swelling risk, and preparation time so hospitals can standardize selection without under-treating complex bleeding.

Manufacturers should strengthen supply-chain resilience for human plasma, bovine, porcine, cellulose, gelatin, collagen, and synthetic inputs while investing in applicator innovation for minimally invasive and robotic surgery. Commercial teams should equip value-analysis committees with real-world evidence, budget-impact models, comparative usability data, and surgeon education. Regulatory teams should align early with FDA, EU MDR, and local requirements to avoid launch delays, documentation gaps, and post-market surveillance deficiencies.

Research Methodology and Evidence Framework

This executive summary is based on a structured secondary-research approach using publicly available and verifiable sources, including regulatory databases, product labeling, clinical literature, hospital blood-management guidance, public health statistics, reimbursement references, procurement signals, and macroeconomic indicators from recognized institutions. Market interpretation considers product class, surgical application, regulatory status, regional access, procurement behavior, and competitive positioning.

Insights are triangulated across clinical evidence, regulatory context, healthcare infrastructure, and commercial adoption signals. The methodology excludes unsupported claims, market sizing, market share, and forecasting, and emphasizes data-backed patterns such as surgical access expansion, aging demographics, increased anticoagulant use, regulatory scrutiny, hospital demand for value-based procurement, and the growing role of real-world evidence in medical product evaluation.

Conclusion: Strategic Outlook for Topical Hemostats

The topical hemostat market is positioned for sustained strategic relevance as surgical teams seek faster, safer, and more procedure-specific bleeding control. Competitive success will depend on more than product availability; it will require clear clinical differentiation, reliable supply, surgeon-friendly delivery, regulatory readiness, and evidence that supports total-cost value.

As AI, advanced biomaterials, minimally invasive surgery, and stricter regulatory expectations reshape the category, manufacturers that combine innovation with real-world outcomes data will be best placed to earn hospital trust. Regional expansion remains attractive, but durable growth will come from aligning premium performance with local reimbursement, procurement expectations, surgical workflow realities, and patient-safety priorities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Topical Hemostat Market, by Product Type
7.1. Introduction
7.2. Mechanical Hemostats
7.2.1. Gelatin-based
7.2.2. Collagen-based
7.2.3. Oxidized Regenerated Cellulose
7.2.4. Polysaccharide-based
7.3. Active Hemostats
7.4. Flowable Hemostats
7.5. Caustic Hemostats
7.5.1. Silver Nitrate
7.5.2. Ferric Subsulfate
7.5.3. Aluminum Chloride
8. Topical Hemostat Market, by Formulation
8.1. Introduction
8.2. Sponges
8.3. Powders
8.4. Sheets
8.5. Pads
8.6. Foams
8.7. Gels
9. Topical Hemostat Market, by Material Source
9.1. Introduction
9.2. Biological Materials
9.3. Plant-derived Materials
9.4. Synthetic Materials
10. Topical Hemostat Market, by Absorbability
10.1. Introduction
10.2. Absorbable Hemostats
10.3. Non-Absorbable Hemostats
11. Topical Hemostat Market, by Application
11.1. Introduction
11.2. Cardiovascular Surgery
11.2.1. Coronary Artery Bypass Grafting
11.2.2. Valve Repair & Replacement
11.2.3. Vascular Grafting
11.3. Dental & Oral Surgery
11.3.1. Tooth Extraction
11.3.2. Periodontal Surgery
11.3.3. Implant Placement
11.4. General Surgery
11.4.1. Abdominal
11.4.2. Gastrointestinal
11.4.3. Hepatobiliary
11.4.4. Colorectal
11.5. Neurosurgery
11.5.1. Cranial
11.5.2. Spinal Neurosurgery
11.5.3. Tumor Resection Procedures
11.6. Orthopedic Surgery
11.6.1. Joint Replacement
11.6.2. Spine
11.7. Gynecological Surgery
11.7.1. Hysterectomy
11.7.2. Myomectomy
11.7.3. Endometriosis
12. Topical Hemostat Market, by End User
12.1. Introduction
12.2. Ambulatory Surgery Centers
12.3. Specialty Clinics
12.4. Hospitals
12.4.1. Private Hospitals
12.4.2. Public Hospitals
12.5. Military & Defense Settings
12.6. Homecare Settings
13. Topical Hemostat Market, by Distribution Channel
13.1. Introduction
13.2. Online
13.3. Offline
14. Topical Hemostat Market, by Region
14.1. Asia-Pacific
14.2. Europe
14.3. North America
14.4. Latin America
14.5. Africa
14.6. Middle East
15. Topical Hemostat Market, by Group
15.1. NATO
15.2. G7
15.3. European Union
15.4. BRICS
15.5. ASEAN
15.6. GCC
16. Topical Hemostat Market, by Country
16.1. United States
16.2. China
16.3. Germany
16.4. Japan
16.5. India
16.6. United Kingdom
16.7. France
16.8. Canada
16.9. Italy
16.10. Australia
16.11. Brazil
16.12. South Korea
16.13. Mexico
16.14. Russia
16.15. Spain
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. FPNV Positioning Matrix, 2025
17.3. Market Concentration Analysis, 2025
17.3.1. Concentration Ratio (CR)
17.3.2. Herfindahl Hirschman Index (HHI)
17.4. Recent Developments & Impact Analysis, 2025
17.5. Product Portfolio Analysis, 2025
17.6. Benchmarking Analysis, 2025
18. Company Profiles
18.1. Aegis Lifesciences Private Limited
18.2. Axio Biosolutions Pvt Ltd
18.3. B.Braun Melsungen AG
18.4. Baxter International, Inc.
18.5. Becton, Dickinson and Company
18.6. Betatech Medical
18.7. BioCer Entwicklungs-GmbH
18.8. Bristol-Myers Squibb Company
18.9. Dilon Technologies Inc
18.10. GELITA MEDICAL GmbH
18.11. Hemostasis, LLC
18.12. Integra LifeSciences Corporation
18.13. Johnson & Johnson Services, Inc.
18.14. Marine Polymer Technologies, Inc.
18.15. Medline Industries, LP
18.16. Medtrade Products Ltd
18.17. Medtronic PLC
18.18. Meril Life Sciences Pvt. Ltd
18.19. Pfizer Inc.
18.20. Southmedic Inc.
18.21. Stryker Corporation
18.22. SYMATESE SAS
18.23. Takeda Pharmaceutical Company Limited
18.24. Teleflex Incorporated
18.25. Zeria Pharmaceutical Co., Ltd.
List of Figures
FIGURE 1. GLOBAL TOPICAL HEMOSTAT MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL TOPICAL HEMOSTAT MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL TOPICAL HEMOSTAT MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL TOPICAL HEMOSTAT MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2025 VS 2032 (%)
FIGURE 9. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2025 VS 2032 (%)
FIGURE 13. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 19. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 23. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 25. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL TOPICAL HEMOSTAT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 27. GLOBAL TOPICAL HEMOSTAT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL TOPICAL HEMOSTAT MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL MECHANICAL HEMOSTATS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL MECHANICAL HEMOSTATS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL MECHANICAL HEMOSTATS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL GELATIN-BASED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL GELATIN-BASED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL GELATIN-BASED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL COLLAGEN-BASED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL COLLAGEN-BASED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL COLLAGEN-BASED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL OXIDIZED REGENERATED CELLULOSE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL OXIDIZED REGENERATED CELLULOSE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL OXIDIZED REGENERATED CELLULOSE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL POLYSACCHARIDE-BASED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL POLYSACCHARIDE-BASED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL POLYSACCHARIDE-BASED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL ACTIVE HEMOSTATS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL ACTIVE HEMOSTATS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL ACTIVE HEMOSTATS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL FLOWABLE HEMOSTATS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL FLOWABLE HEMOSTATS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL FLOWABLE HEMOSTATS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL CAUSTIC HEMOSTATS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL CAUSTIC HEMOSTATS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL CAUSTIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL SILVER NITRATE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL SILVER NITRATE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL SILVER NITRATE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL FERRIC SUBSULFATE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL FERRIC SUBSULFATE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL FERRIC SUBSULFATE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL ALUMINUM CHLORIDE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL ALUMINUM CHLORIDE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL ALUMINUM CHLORIDE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL SPONGES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL SPONGES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL SPONGES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL POWDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL POWDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL POWDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL SHEETS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL SHEETS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL SHEETS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL PADS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL PADS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL PADS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL FOAMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL FOAMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL FOAMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL GELS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL GELS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL GELS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL BIOLOGICAL MATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL BIOLOGICAL MATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL BIOLOGICAL MATERIALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL PLANT-DERIVED MATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL PLANT-DERIVED MATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL PLANT-DERIVED MATERIALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL SYNTHETIC MATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL SYNTHETIC MATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL SYNTHETIC MATERIALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL ABSORBABLE HEMOSTATS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL ABSORBABLE HEMOSTATS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL ABSORBABLE HEMOSTATS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL NON-ABSORBABLE HEMOSTATS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL NON-ABSORBABLE HEMOSTATS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL NON-ABSORBABLE HEMOSTATS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL CARDIOVASCULAR SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL CARDIOVASCULAR SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL CARDIOVASCULAR SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL CORONARY ARTERY BYPASS GRAFTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL CORONARY ARTERY BYPASS GRAFTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL CORONARY ARTERY BYPASS GRAFTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL VALVE REPAIR & REPLACEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL VALVE REPAIR & REPLACEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL VALVE REPAIR & REPLACEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL VASCULAR GRAFTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL VASCULAR GRAFTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL VASCULAR GRAFTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL DENTAL & ORAL SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL DENTAL & ORAL SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL DENTAL & ORAL SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL TOOTH EXTRACTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL TOOTH EXTRACTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL TOOTH EXTRACTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL PERIODONTAL SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL PERIODONTAL SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL PERIODONTAL SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL IMPLANT PLACEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL IMPLANT PLACEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL IMPLANT PLACEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL GENERAL SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL GENERAL SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL GENERAL SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL ABDOMINAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL ABDOMINAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL ABDOMINAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL GASTROINTESTINAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL GASTROINTESTINAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL GASTROINTESTINAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL HEPATOBILIARY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL HEPATOBILIARY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL HEPATOBILIARY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL COLORECTAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL COLORECTAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL COLORECTAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL NEUROSURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL NEUROSURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL NEUROSURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL CRANIAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL CRANIAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL CRANIAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL SPINAL NEUROSURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL SPINAL NEUROSURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL SPINAL NEUROSURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL TUMOR RESECTION PROCEDURES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL TUMOR RESECTION PROCEDURES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL TUMOR RESECTION PROCEDURES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL SPINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL SPINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL SPINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL GYNECOLOGICAL SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL GYNECOLOGICAL SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL GYNECOLOGICAL SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL HYSTERECTOMY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL HYSTERECTOMY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL HYSTERECTOMY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL MYOMECTOMY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL MYOMECTOMY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL MYOMECTOMY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL ENDOMETRIOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL ENDOMETRIOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL ENDOMETRIOSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 154. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 155. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 157. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 158. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 159. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 160. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 161. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 162. GLOBAL MILITARY & DEFENSE SETTINGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 163. GLOBAL MILITARY & DEFENSE SETTINGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 164. GLOBAL MILITARY & DEFENSE SETTINGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 165. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 166. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 167. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 168. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 169. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 170. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 171. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 172. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 173. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 174. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 175. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY MECHANICAL HEMOSTATS, 2017-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY CAUSTIC HEMOSTATS, 2017-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2017-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2017-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL & ORAL SURGERY, 2017-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2017-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 193. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 194. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 195. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY MECHANICAL HEMOSTATS, 2017-2032 (USD MILLION)
TABLE 196. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY CAUSTIC HEMOSTATS, 2017-2032 (USD MILLION)
TABLE 197. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 198. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2017-2032 (USD MILLION)
TABLE 199. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2017-2032 (USD MILLION)
TABLE 200. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 201. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 202. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL & ORAL SURGERY, 2017-2032 (USD MILLION)
TABLE 203. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 204. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2017-2032 (USD MILLION)
TABLE 205. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 206. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 207. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 208. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 209. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 210. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 211. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 212. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY MECHANICAL HEMOSTATS, 2017-2032 (USD MILLION)
TABLE 213. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY CAUSTIC HEMOSTATS, 2017-2032 (USD MILLION)
TABLE 214. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 215. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2017-2032 (USD MILLION)
TABLE 216. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2017-2032 (USD MILLION)
TABLE 217. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 218. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 219. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL & ORAL SURGERY, 2017-2032 (USD MILLION)
TABLE 220. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 221. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2017-2032 (USD MILLION)
TABLE 222. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 223. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 224. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 225. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 226. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 227. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 228. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 229. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY MECHANICAL HEMOSTATS, 2017-2032 (USD MILLION)
TABLE 230. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY CAUSTIC HEMOSTATS, 2017-2032 (USD MILLION)
TABLE 231. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 232. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2017-2032 (USD MILLION)
TABLE 233. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2017-2032 (USD MILLION)
TABLE 234. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 235. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 236. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL & ORAL SURGERY, 2017-2032 (USD MILLION)
TABLE 237. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 238. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2017-2032 (USD MILLION)
TABLE 239. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 240. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 241. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 242. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 243. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 244. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 245. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 246. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY MECHANICAL HEMOSTATS, 2017-2032 (USD MILLION)
TABLE 247. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY CAUSTIC HEMOSTATS, 2017-2032 (USD MILLION)
TABLE 248. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 249. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2017-2032 (USD MILLION)
TABLE 250. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2017-2032 (USD MILLION)
TABLE 251. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 252. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 253. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL & ORAL SURGERY, 2017-2032 (USD MILLION)
TABLE 254. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 255. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2017-2032 (USD MILLION)
TABLE 256. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 257. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 258. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 259. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 260. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 261. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 262. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 263. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY MECHANICAL HEMOSTATS, 2017-2032 (USD MILLION)
TABLE 264. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY CAUSTIC HEMOSTATS, 2017-2032 (USD MILLION)
TABLE 265. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 266. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2017-2032 (USD MILLION)
TABLE 267. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2017-2032 (USD MILLION)
TABLE 268. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 269. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 270. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL & ORAL SURGERY, 2017-2032 (USD MILLION)
TABLE 271. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 272. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2017-2032 (USD MILLION)
TABLE 273. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 274. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 275. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 276. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 277. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 278. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 279. NATO TOPICAL HEMOSTAT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 280. NATO TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 281. NATO TOPICAL HEMOSTAT MARKET SIZE, BY MECHANICAL HEMOSTATS, 2017-2032 (USD MILLION)
TABLE 282. NATO TOPICAL HEMOSTAT MARKET SIZE, BY CAUSTIC HEMOSTATS, 2017-2032 (USD MILLION)
TABLE 283. NATO TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 284. NATO TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2017-2032 (USD MILLION)
TABLE 285. NATO TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2017-2032 (USD MILLION)
TABLE 286. NATO TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 287. NATO TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 288. NATO TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL & ORAL SURGERY, 2017-2032 (USD MILLION)
TABLE 289. NATO TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 290. NATO TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2017-2032 (USD MILLION)
TABLE 291. NATO TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 292. NATO TOPICAL HEMOSTAT MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 293. NATO TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 294. NATO TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 295. NATO TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 296. G7 TOPICAL HEMOSTAT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 297. G7 TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 298. G7 TOPICAL HEMOSTAT MARKET SIZE, BY MECHANICAL HEMOSTATS, 2017-2032 (USD MILLION)
TABLE 299. G7 TOPICAL HEMOSTAT MARKET SIZE, BY CAUSTIC HEMOSTATS, 2017-2032 (USD MILLION)
TABLE 300. G7 TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 301. G7 TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2017-2032 (USD MILLION)
TABLE 302. G7 TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2017-2032 (USD MILLION)
TABLE 303. G7 TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 304. G7 TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 305. G7 TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL & ORAL SURGERY, 2017-2032 (USD MILLION)
TABLE 306. G7 TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 307. G7 TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2017-2032 (USD MILLION)
TABLE 308. G7 TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 309. G7 TOPICAL HEMOSTAT MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 310. G7 TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 311. G7 TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 312. G7 TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 313. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 314. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 315. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY MECHANICAL HEMOSTATS, 2017-2032 (USD MILLION)
TABLE 316. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY CAUSTIC HEMOSTATS, 2017-2032 (USD MILLION)
TABLE 317. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 318. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2017-2032 (USD MILLION)
TABLE 319. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2017-2032 (USD MILLION)
TABLE 320. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 321. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 322. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL & ORAL SURGERY, 2017-2032 (USD MILLION)
TABLE 323. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 324. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2017-2032 (USD MILLION)
TABLE 325. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 326. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 327. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 328. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 329. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 330. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 331. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 332. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY MECHANICAL HEMOSTATS, 2017-2032 (USD MILLION)
TABLE 333. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY CAUSTIC HEMOSTATS, 2017-2032 (USD MILLION)
TABLE 334. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 335. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2017-2032 (USD MILLION)
TABLE 336. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2017-2032 (USD MILLION)
TABLE 337. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 338. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 339. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL & ORAL SURGERY, 2017-2032 (USD MILLION)
TABLE 340. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 341. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2017-2032 (USD MILLION)
TABLE 342. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 343. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 344. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 345. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 346. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 347. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 348. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 349. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY MECHANICAL HEMOSTATS, 2017-2032 (USD MILLION)
TABLE 350. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY CAUSTIC HEMOSTATS, 2017-2032 (USD MILLION)
TABLE 351. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 352. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2017-2032 (USD MILLION)
TABLE 353. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2017-2032 (USD MILLION)
TABLE 354. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 355. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 356. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL & ORAL SURGERY, 2017-2032 (USD MILLION)
TABLE 357. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2017-2032 (USD MILLION)
TABLE 358. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2017-2032 (USD MILLION)
TABLE 359. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 360. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 361. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 362. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 363. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 364. GCC TOPICAL HEMOSTAT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 365. GCC TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 366. GCC TOPICAL HEMOSTAT MARKET SIZE, BY MECHANICAL HEMOSTATS, 2017-2032 (USD MILLION)
TABLE 367. GCC TOPICAL HEMOSTAT MARKET SIZE, BY CAUSTIC HEMOSTATS, 2017-2032 (USD MILLION)
TABLE 368. GCC TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 369. GCC TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2017-2032 (USD MILLION)
TABLE 370. GCC TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2017-2032 (USD MILLION)
TABLE 371. GCC TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TAB

Companies Mentioned

  • Aegis Lifesciences Private Limited
  • Axio Biosolutions Pvt Ltd
  • B.Braun Melsungen AG
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Betatech Medical
  • BioCer Entwicklungs-GmbH
  • Bristol-Myers Squibb Company
  • Dilon Technologies Inc
  • GELITA MEDICAL GmbH
  • Hemostasis, LLC
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Marine Polymer Technologies, Inc.
  • Medline Industries, LP
  • Medtrade Products Ltd
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd
  • Pfizer Inc.
  • Southmedic Inc.
  • Stryker Corporation
  • SYMATESE SAS
  • Takeda Pharmaceutical Company Limited
  • Teleflex Incorporated
  • Zeria Pharmaceutical Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages181
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 7.2 Billion
Forecasted Market Value ( USD ) by 2032 $ 11.51 Billion
Compound Annual Growth Rate8.0%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Oxidized Regenerated Cellulose Based Hemostats Market - Global Forecast 2026-2032 - Product Image

Oxidized Regenerated Cellulose Based Hemostats Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Hemostats and Tissue Sealants - Global Strategic Business Report - Product Image

Hemostats and Tissue Sealants - Global Strategic Business Report

  • Report
  • 476 Pages
  • Global
From
Hemostats Market - Global Forecast 2026-2032 - Product Image

Hemostats Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Topical Absorbable Hemostats Market Report 2026 - Product Image

Topical Absorbable Hemostats Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers - Global Strategic Business Report - Product Image

Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers - Global Strategic Business Report

  • Report
  • 377 Pages
  • Global
From

About the Topical Hemostat Market

In the field of wound care, the Topical Hemostat market encompasses a range of products designed to promote hemostasis, which is the process of blood clot formation to stop bleeding. These products are particularly crucial in surgical procedures, trauma situations, and in treating individuals with clotting deficiencies. Topical hemostats are available in various forms, including granular powders, films, pads, and gels. They work by different mechanisms; some provide a physical barrier to bleeding, while others promote the aggregation of platelets or catalyze the clotting process through biological or synthetic materials. The choice of topical hemostat may depend on factors such as the nature and location of the wound, the extent of bleeding, and any underlying patient conditions. With ongoing research and development, the market has seen the introduction of more advanced hemostatic agents that offer improved efficacy, faster action, and greater biocompatibility. Several companies are prominent in the Topical Hemostat market, maintaining a strong presence in the wound care sector. Notable players include Johnson & Johnson (with its ETHICON subsidiary), Baxter International Inc., Becton, Dickinson and Company (BD), CryoLife Inc., Pfizer Inc., and Z-Medica, LLC. These companies engage in the development, manufacturing, and distribution of hemostatic products, and often invest in research to advance the field of topical hemostasis further. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.